Rob Hotakainen, San Diego Union Tribune, August 12, 2016
Delivering a major blow to backers of pot legalization, the Obama administration said Thursday that it would keep marijuana classified as one of the nation's most dangerous drugs, similar to heroin and LSD.
The long-awaited decision by the U.S. Drug Enforcement Administration keeps intact a 1970 law that lists marijuana as Schedule 1 drug, one defined as having no medical value. That runs counter to decisions made by California and 25 other states that have already approved use of the drug as medicine.
Peter Hecht and Christopher Cadelago, The Sacramento Bee, August 11, 2016
Federal authorities Thursday announced they were standing firm on a 46-year-old policy of classifying marijuana as a dangerous narcotic with no accepted medical use.
But in a seemingly contradictory decision, the Drug Enforcement Administration also said it was lifting long-standing restrictions on cultivation to facilitate research of marijuana’s potential effectiveness as medicine for a range of conditions. That decision will end a restrictive monopoly, in which the only marijuana federally sanctioned for medical studies was grown under a government contract with the University of Mississippi.
Lisa Ellis, Practical Pain Management, August 1, 2016
An interview with Barth Wilsey, MD
A growing number of states have approved medical marijuana (cannabis) to treat a variety of conditions, including neuropathic pain, spasticity, and pediatric epilepsy. Despite the increasing popularity of these treatments, there’s been an absence of uniform standards and guidelines in place to help medical professionals navigate the rapidly changing landscape in the most effective way. As a result, many pain specialists are left grappling with a host of important issues when it comes to incorporating cannabis into a broader pain treatment strategy. Here is some insight from an experienced practitioner on treating pain with cannabis.